‘Ireland, a bridgehead for companies entering the EU mkt'
By Nho, Byung Chul | translator Kang, Shin-Kook
24.07.10 05:35:26
가나다라
0
Has the lowest corporate tax rate in the world, at 15/12.5% for large/small and medium companies
Pfizer, BMS, etc. are expanding production bases... own abundant specialized labor force
Wuxi and Takeda also enter Ireland...SK Biotech also recently acquired a plant
▲Rory Mullen, Global Head of Biopharma and Food at Investment Promotion & Development Agency Ireland
"Ireland has the best condition for multinational pharmaceutical and biotech companies to invest and operate in as a bridgehead to the European market."Rory Mullen, Global Head of Biopharma and Food at Investment Promotion & Development Agency Ireland explained so during his recent visit to South Korea. Mr. Mullen visited Korea to discuss European expansion strategies with the country's health authorities and pharma and bio companies.
He cited Ireland's abundant R&D talent, low corporate taxes, business-friendly state policies, and EU-GMP certification as some of the benefits.
Global Head Mullen said, “Ireland's pharma and biotech industry is 95% foreign-owned, with acad
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)